PŘIKRYL, Radovan, Hana PŘIKRYLOVÁ KUČEROVÁ, Michaela VRZALOVÁ a Eva ČEŠKOVÁ. Role of Long-Acting Injectable Second-Generation Antipsychotics in the Treatment of First-Episode Schizophrenia: A Clinical Perspective. Online. Schizophrenia Research and Treatment. USA: Hindawi Publishing Corporation, 2012, roč. 2012, Feb, s. "nestránkováno", 7 s. ISSN 2090-2085. Dostupné z: https://dx.doi.org/10.1155/2012/764769. [citováno 2024-04-23] |
Další formáty:
BibTeX
LaTeX
RIS
@article{981452, author = {Přikryl, Radovan and Přikrylová Kučerová, Hana and Vrzalová, Michaela and Češková, Eva}, article_location = {USA}, article_number = {Feb}, doi = {http://dx.doi.org/10.1155/2012/764769}, keywords = {first episode schizophrenia; injectable; second generation antipsychotics;}, language = {eng}, issn = {2090-2085}, journal = {Schizophrenia Research and Treatment}, title = {Role of Long-Acting Injectable Second-Generation Antipsychotics in the Treatment of First-Episode Schizophrenia: A Clinical Perspective}, url = {http://www.hindawi.com/journals/sprt/2012/764769/}, volume = {2012}, year = {2012} }
TY - JOUR ID - 981452 AU - Přikryl, Radovan - Přikrylová Kučerová, Hana - Vrzalová, Michaela - Češková, Eva PY - 2012 TI - Role of Long-Acting Injectable Second-Generation Antipsychotics in the Treatment of First-Episode Schizophrenia: A Clinical Perspective JF - Schizophrenia Research and Treatment VL - 2012 IS - Feb SP - "nestránkováno" EP - "nestránkováno" PB - Hindawi Publishing Corporation SN - 20902085 KW - first episode schizophrenia KW - injectable KW - second generation antipsychotics; UR - http://www.hindawi.com/journals/sprt/2012/764769/ L2 - http://www.hindawi.com/journals/sprt/2012/764769/ N2 - Approximately 80% of patients with the first-episode schizophrenia reach symptomatic remission after antipsychotic therapy. However, within two years most of them relapse, mainly due to low levels of insight into the illness and nonadherence to their oral medication. Therefore, although the formal data available is limited, many experts recommend prescribing long-acting injectable second-generation antipsychotics (mostly risperidone or alternatively paliperidone) in the early stages of schizophrenia, particularly in patients who have benefited from the original oral molecule in the past and agree to receive long-term injectable treatment. Early application of long-acting injectable second-generation antipsychotics can significantly reduce the risk of relapse in the future and thus improve not only the social and working potential of patients with schizophrenia but also their quality of life. ER -
PŘIKRYL, Radovan, Hana PŘIKRYLOVÁ KUČEROVÁ, Michaela VRZALOVÁ a Eva ČEŠKOVÁ. Role of Long-Acting Injectable Second-Generation Antipsychotics in the Treatment of First-Episode Schizophrenia: A Clinical Perspective. Online. \textit{Schizophrenia Research and Treatment}. USA: Hindawi Publishing Corporation, 2012, roč.~2012, Feb, s.~''nestránkováno'', 7 s. ISSN~2090-2085. Dostupné z: https://dx.doi.org/10.1155/2012/764769. [citováno 2024-04-23]
|